id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-N-0044-0001,FDA,FDA-2000-N-0044,Requirements on Content and Format of Labeling for Human Prescription Drugs and Biologics; Requirements for Prescription Drug Porduct Lables - Notice of Proposed Rule (part 3 of 3),Notice,NPR-Notice of Proposed Rule-Making,2000-12-27T05:00:00Z,2000,12,2000-12-27T05:00:00Z,2001-03-23T04:59:59Z,2011-06-11T16:25:50Z,,0,0,09000064804aefe4
FDA-2000-N-0044-0002,FDA,FDA-2000-N-0044,Requirements on Content and Format of Labeling for Human Prescription Drugs and Biologics; Requirements for Prescription Drug Porduct Lables - Notice of Proposed Rule (part 1 of 3),Notice,NPR-Notice of Proposed Rule-Making,2000-12-27T05:00:00Z,2000,12,2000-12-27T05:00:00Z,2001-03-23T04:59:59Z,2011-06-11T16:25:48Z,,0,0,09000064804af000
FDA-2000-N-0044-0003,FDA,FDA-2000-N-0044,Requirements on Content and Format of Labeling for Human Prescription Drugs and Biologics; Requirements for Prescription Drug Porduct Lables - Notice of Proposed Rule (part 2 of 3),Notice,NPR-Notice of Proposed Rule-Making,2000-12-27T05:00:00Z,2000,12,2000-12-27T05:00:00Z,2001-03-23T04:59:59Z,2011-06-11T16:25:49Z,,0,0,09000064804af001